A PHASE III STUDY TO EVALUATE THE SAFETY AND EFFICACY OF GANCICLOVIR (DIHYDROXYPROPOXYMETHYL GUANINE [DHPG]) TREATMENT OF SYMPTOMATIC CENTRAL NERVOUS SYSTEM (CNS) CONGENITAL CYTOMEGALOVIRUS (CMV) INFECTIONS.: